Marijuana trials should aim for higher standard: superiority to Marinol, FDA's Temple suggests.
Executive Summary
MARIJUANA STUDIES NEED TO SHOW ADVANTAGE OVER MARINOL TO CONVINCE "SKEPTICS" of the merits of smoked marijuana as medical therapy, Center for Drug Evaluation & Research Associate Director for Medical Policy Robert Temple, MD, predicted at an NIH scientific workshop on the medical utility of marijuana Feb. 19 in Bethesda, Md. "Smoked marijuana is going to have to [be] better than what's available to be persuasive," Temple asserted.